Market Capitalization of Vilin Bio Med (VILINBIO)
Vilin Bio Med (VILINBIO) is a Healthcare sector company. Live share price data is currently unavailable, however you can explore VILINBIO financial statements, balance sheet and fundamentals below. Log your investment research and trade decisions in Tickjournal's free trading journal. Compare with VILINBIO fair price to assess whether the stock is under or overvalued.
Stock Price Data Not Available
Historical market capitalization trends require stock price information, which is currently not available for Vilin Bio Med (VILINBIO). However, you can explore comprehensive financial statements and data for this company below.
Income Statement Summary - Vilin Bio Med
Revenue, profitability, and earnings data (8 periods of data available)
| Period | Revenue | EBITDA | Operating Profit | Net Profit | EPS | Operating Margin |
|---|---|---|---|---|---|---|
| None | ₹8.0 Cr | ₹2.0 Cr | ₹2.0 Cr | ₹1.0 Cr | ₹2.2 | 8.0% |
| March 2026 | ₹42.0 Cr | ₹3.0 Cr | ₹3.0 Cr | ₹2.0 Cr | ₹1.37 | 8.0% |
| March 2025 | ₹15.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.16 | 5.0% |
| March 2024 | ₹16.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.12 | 5.0% |
| March 2023 | ₹12.0 Cr | ₹3.0 Cr | ₹3.0 Cr | ₹1.0 Cr | ₹1.25 | 21.0% |
| March 2022 | ₹11.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.1 | 7.0% |
| March 2021 | ₹12.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.15 | 7.0% |
| March 2020 | ₹17.0 Cr | ₹1.0 Cr | ₹1.0 Cr | ₹0.0 Cr | ₹0.2 | 5.0% |
Balance Sheet Summary - Vilin Bio Med
Assets, liabilities, and equity data (7 years of data available)
| Year | Total Assets | Fixed Assets | Current Assets | Total Equity | Total Liabilities | Current Liabilities | Current Ratio |
|---|---|---|---|---|---|---|---|
| 2026 | ₹35.0 Cr | ₹3.0 Cr | ₹27.0 Cr | ₹28.0 Cr | - | ₹0.0 Cr | - |
| 2025 | ₹28.0 Cr | ₹1.0 Cr | ₹13.0 Cr | ₹23.0 Cr | - | ₹0.0 Cr | - |
| 2024 | ₹32.0 Cr | ₹1.0 Cr | ₹19.0 Cr | ₹23.0 Cr | - | ₹0.0 Cr | - |
| 2023 | ₹18.0 Cr | ₹2.0 Cr | ₹8.0 Cr | ₹11.0 Cr | - | ₹1.0 Cr | 8.0 |
| 2022 | ₹14.0 Cr | ₹2.0 Cr | ₹12.0 Cr | ₹7.0 Cr | - | ₹1.0 Cr | 12.0 |
| 2021 | ₹14.0 Cr | ₹2.0 Cr | ₹12.0 Cr | ₹7.0 Cr | - | ₹1.0 Cr | 12.0 |
| 2020 | ₹14.0 Cr | ₹2.0 Cr | ₹12.0 Cr | ₹7.0 Cr | - | ₹0.0 Cr | - |
Cash Flow Statement - Vilin Bio Med
Operating, investing, and financing cash flows (6 periods of data available)
| Period | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Flow |
|---|---|---|---|---|
| March 2025 | ₹0.0 Cr | ₹-1.0 Cr | ₹-5.0 Cr | ₹-6.0 Cr |
| March 2024 | ₹-7.0 Cr | ₹0.0 Cr | ₹9.0 Cr | ₹2.0 Cr |
| March 2023 | ₹-2.0 Cr | ₹0.0 Cr | ₹2.0 Cr | ₹0.0 Cr |
| March 2022 | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr | ₹0.0 Cr |
| March 2021 | ₹-1.0 Cr | ₹0.0 Cr | ₹1.0 Cr | ₹0.0 Cr |
| March 2020 | ₹-2.0 Cr | ₹0.0 Cr | ₹2.0 Cr | ₹0.0 Cr |
About Market Capitalization
Why is market cap important?
Market capitalization represents the total market value of a company's outstanding shares. It helps investors assess company size, compare valuations across sectors, and make informed portfolio allocation decisions. For live price, earnings and the complete company profile, see Vilin Bio Med share price screener.
- Assess company size and investment risk
- Compare companies across sectors
- Track valuation trends over time
- Make informed portfolio allocation decisions
What happens when price data is unavailable?
While we cannot show historical market cap trends without stock price data, you can still assess the company's financial strength using metrics like revenue, profitability, debt ratios, and asset values shown in the financial statements above. View VILINBIO yearly price range for the annual high/low range and current price position.